CD8A and type 1 diabetes mellitus: In the patients with type 1 diabetes with anti-VCA IgG antibodies, A statistically relevant higher percentage (p = 0.033) (Figure 4) and absolute number (p = 0.041) of CD3+CD8+ T lymphocytes were found compared to the patients without anti-VCA antibodies.